Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiko Shimada

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Clinical Cardiology|April 16, 2010
Long-term outcome of patients treated with prophylactic nesiritide for the prevention of acute kidney injury following cardiovascular surgeryVijaykumar Lingegowda, Quoc C Van, Michiko Shimada, et al.
BMC Nephrology|March 30, 2013
A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathyMichiko Shimada, Takeshi Fujita, Norio Nakamura, et al.
BMC Cancer|November 28, 2012
A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion geneHisashi Tanaka, Akihito Hayashi, Takeshi Morimoto, et al.
Hypertension (Dallas, Tex. : 1979)|October 19, 2005
Intracellular signaling for vasoconstrictor coupling factor 6: novel function of beta-subunit of ATP synthase as receptorTomohiro Osanai, Koji Magota, Makoto Tanaka, et al.
In Vivo (Athens, Greece)|October 16, 2008
Serum lipid profile and plasma fatty acid composition in hemodialysis patients--comparison with chronic kidney disease patientsNorio Nakamura, Takeshi Fujita, Ryuichiro Kumasaka, et al.
Lancet (London, England)|September 19, 2006
Systemic lupus erythematosus and blood typeNorio Nakamura, Takeshi Fujita, Masayuki Nakamura, et al.
Journal of the American Heart Association|April 9, 2019
Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor PathwayHiroaki Ichikawa, Michiko Shimada, Masato Narita, et al.
In Vivo (Athens, Greece)|April 26, 2017
Factors Associated with Microalbuminuria Remission in Patients with Type 2 Diabetes: Importance of Early Intervention for Microalbuminuric Patients (TSUGARU STUDY)Norio Nakamura, Ikuyo Narita, Takeshi Fujita, et al.
Nephrology (Carlton, Vic.)|November 21, 2008
Extracellular matrix metalloproteinase inducer is expressed in the proximal tubular epithelial cells of the human kidneyMichiko Shimada, Hideaki Yamabe, Hiroshi Osawa, et al.
Kidney International|May 21, 2010
Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosisEduardo H Garin, Wei Mu, John M Arthur, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Clinical Cardiology|April 16, 2010
Long-term outcome of patients treated with prophylactic nesiritide for the prevention of acute kidney injury following cardiovascular surgeryVijaykumar Lingegowda, Quoc C Van, Michiko Shimada, et al.
BMC Nephrology|March 30, 2013
A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathyMichiko Shimada, Takeshi Fujita, Norio Nakamura, et al.
BMC Cancer|November 28, 2012
A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion geneHisashi Tanaka, Akihito Hayashi, Takeshi Morimoto, et al.
Hypertension (Dallas, Tex. : 1979)|October 19, 2005
Intracellular signaling for vasoconstrictor coupling factor 6: novel function of beta-subunit of ATP synthase as receptorTomohiro Osanai, Koji Magota, Makoto Tanaka, et al.
In Vivo (Athens, Greece)|October 16, 2008
Serum lipid profile and plasma fatty acid composition in hemodialysis patients--comparison with chronic kidney disease patientsNorio Nakamura, Takeshi Fujita, Ryuichiro Kumasaka, et al.
Lancet (London, England)|September 19, 2006
Systemic lupus erythematosus and blood typeNorio Nakamura, Takeshi Fujita, Masayuki Nakamura, et al.
Journal of the American Heart Association|April 9, 2019
Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor PathwayHiroaki Ichikawa, Michiko Shimada, Masato Narita, et al.
In Vivo (Athens, Greece)|April 26, 2017
Factors Associated with Microalbuminuria Remission in Patients with Type 2 Diabetes: Importance of Early Intervention for Microalbuminuric Patients (TSUGARU STUDY)Norio Nakamura, Ikuyo Narita, Takeshi Fujita, et al.
Nephrology (Carlton, Vic.)|November 21, 2008
Extracellular matrix metalloproteinase inducer is expressed in the proximal tubular epithelial cells of the human kidneyMichiko Shimada, Hideaki Yamabe, Hiroshi Osawa, et al.
Kidney International|May 21, 2010
Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosisEduardo H Garin, Wei Mu, John M Arthur, et al.
Pageof 9